Proton Therapy Publication
August 2023
Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands.
Link to the fully detailed content
Proton Therapy Publication
July 2023
Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experience.
Link to the fully detailed content
Proton Therapy Publication
June 2023
Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer.
Link to the fully detailed content
Proton Therapy Publication
June 2023
Particle beam therapy versus photon radiotherapy for extrahepatic biliary cancer-systemic review and meta-analysis.
Link to the fully detailed content
Webinar
March 29, 2023
Hypofractionation in Proton Therapy: radiobiological bases and clinical applications
Roberto
Orecchia
Barbara
Jereczek
Daniela
Alterio
Dante
Amelio
Jiri
Kubes
Link to the fully detailed content
Proton Therapy Publication
April 2023
Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis.
Link to the fully detailed content
Proton Therapy Publication
January 2023
A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer Patients.
Link to the fully detailed content
Proton Therapy Publication
December 2022
Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability.
Link to the fully detailed content
Proton Therapy Publication
November 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Link to the fully detailed content
Proton Therapy Publication
November 2022
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.
Link to the fully detailed content